Cargando…

The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma

Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective to combine with neoadjuvant chemotherapy for McKeown minimally invasive esophagectomy. In addition, the two groups were similar in terms of the recovery time, hospital discharge day,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yan, Hao, Wentao, Li, Yin, Liu, Xianben, Wang, Zongfei, Sun, Haibo, Liu, Shilei, Xing, Wenqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472249/
https://www.ncbi.nlm.nih.gov/pubmed/36119515
http://dx.doi.org/10.3389/fonc.2022.906439
_version_ 1784789267081330688
author Zheng, Yan
Hao, Wentao
Li, Yin
Liu, Xianben
Wang, Zongfei
Sun, Haibo
Liu, Shilei
Xing, Wenqun
author_facet Zheng, Yan
Hao, Wentao
Li, Yin
Liu, Xianben
Wang, Zongfei
Sun, Haibo
Liu, Shilei
Xing, Wenqun
author_sort Zheng, Yan
collection PubMed
description Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective to combine with neoadjuvant chemotherapy for McKeown minimally invasive esophagectomy. In addition, the two groups were similar in terms of the recovery time, hospital discharge day, and early resumption of oral feeding. OBJECTIVES: To evaluate the safety of early oral feeding (EOF) combined with neoadjuvant chemotherapy (NAC) of esophagectomy. SUMMARY BACKGROUND DATA: Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective for primary surgery esophageal cancer patients. METHODS: We retrospectively evaluated consecutive patients who underwent non-tube no fasting and McKeown minimally invasive (MIE). They were divided into two groups: one received NAC, and the other received primary surgery. Complications after the operation, postoperative CRG complications, operative time, operative bleeding, and length of stay were evaluated. RESULTS: Between 01/2014 and 12/2017, there hundred and eighty two consecutive patients underwent MIE with total two-field lymphadenectomy under the non-tube no fasting fast-track surgery program. A total of 137 patients received NAC, and 245 accepted primary surgery. Propensity score matching was used to compare NAC patients with 62 matched patients from each group. The NAC group had a similar number of total complications as the primary surgery group (32.26% in the primary surgery group vs. 25.81% in the NAC group; p=0.429) and had the same median postoperative hospitalization duration (8 days, p=0.723). CONCLUSIONS: After McKeown MIE, the patients receiving NAC combined with “non-tube no fasting” FTS had a similar incidence of postoperative complications outcomes as those without NAC. In addition, the two groups were similar in terms of the recovery time, hospital discharge day, and early resumption of oral feeding.
format Online
Article
Text
id pubmed-9472249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94722492022-09-15 The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma Zheng, Yan Hao, Wentao Li, Yin Liu, Xianben Wang, Zongfei Sun, Haibo Liu, Shilei Xing, Wenqun Front Oncol Oncology Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective to combine with neoadjuvant chemotherapy for McKeown minimally invasive esophagectomy. In addition, the two groups were similar in terms of the recovery time, hospital discharge day, and early resumption of oral feeding. OBJECTIVES: To evaluate the safety of early oral feeding (EOF) combined with neoadjuvant chemotherapy (NAC) of esophagectomy. SUMMARY BACKGROUND DATA: Our non-tube no fasting (early oral feeding and no nasogastric tube) fast-track surgery (FTS) was safe and effective for primary surgery esophageal cancer patients. METHODS: We retrospectively evaluated consecutive patients who underwent non-tube no fasting and McKeown minimally invasive (MIE). They were divided into two groups: one received NAC, and the other received primary surgery. Complications after the operation, postoperative CRG complications, operative time, operative bleeding, and length of stay were evaluated. RESULTS: Between 01/2014 and 12/2017, there hundred and eighty two consecutive patients underwent MIE with total two-field lymphadenectomy under the non-tube no fasting fast-track surgery program. A total of 137 patients received NAC, and 245 accepted primary surgery. Propensity score matching was used to compare NAC patients with 62 matched patients from each group. The NAC group had a similar number of total complications as the primary surgery group (32.26% in the primary surgery group vs. 25.81% in the NAC group; p=0.429) and had the same median postoperative hospitalization duration (8 days, p=0.723). CONCLUSIONS: After McKeown MIE, the patients receiving NAC combined with “non-tube no fasting” FTS had a similar incidence of postoperative complications outcomes as those without NAC. In addition, the two groups were similar in terms of the recovery time, hospital discharge day, and early resumption of oral feeding. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9472249/ /pubmed/36119515 http://dx.doi.org/10.3389/fonc.2022.906439 Text en Copyright © 2022 Zheng, Hao, Li, Liu, Wang, Sun, Liu and Xing https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zheng, Yan
Hao, Wentao
Li, Yin
Liu, Xianben
Wang, Zongfei
Sun, Haibo
Liu, Shilei
Xing, Wenqun
The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
title The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
title_full The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
title_fullStr The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
title_full_unstemmed The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
title_short The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
title_sort safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472249/
https://www.ncbi.nlm.nih.gov/pubmed/36119515
http://dx.doi.org/10.3389/fonc.2022.906439
work_keys_str_mv AT zhengyan thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT haowentao thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT liyin thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT liuxianben thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT wangzongfei thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT sunhaibo thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT liushilei thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT xingwenqun thesafetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT zhengyan safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT haowentao safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT liyin safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT liuxianben safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT wangzongfei safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT sunhaibo safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT liushilei safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma
AT xingwenqun safetyofneoadjuvantchemotherapycombinedwithnontubenofastingfasttracksurgeryforesophagealcarcinoma